Patents by Inventor Jingpin Jia

Jingpin Jia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • APIXABAN FORMULATIONS
    Publication number: 20200375968
    Abstract: Compositions comprising crystalline apixaban particles having a D90 equal to or less than 89 ?m, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to for the treatment and/or prophylaxis of thromboembolic disorders.
    Type: Application
    Filed: May 14, 2020
    Publication date: December 3, 2020
    Inventors: Jatin Patel, Charles Frost, Jingpin Jia, Chandra Vemavarapu
  • APIXABAN FORMULATIONS
    Publication number: 20170202825
    Abstract: Compositions comprising crystalline apixaban particles having a D90 equal to or less than 89 ?m, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to for the treatment and/or prophylaxis of thromboembolic disorders.
    Type: Application
    Filed: March 30, 2017
    Publication date: July 20, 2017
    Inventors: Jatin Patel, Charles Frost, Jingpin Jia, Chandra Vemavarapu
  • APIXABAN FORMULATIONS
    Publication number: 20170202824
    Abstract: Compositions comprising crystalline apixaban particles having a D90 equal to or less than 89 ?m, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to for the treatment and/or prophylaxis of thromboembolic disorders.
    Type: Application
    Filed: March 30, 2017
    Publication date: July 20, 2017
    Inventors: Jatin Patel, Charles Frost, Jingpin Jia, Chandra Vemavarapu
  • APIXABAN FORMULATIONS
    Publication number: 20160243101
    Abstract: Compositions comprising crystalline apixaban particles having a D90 equal to or less than 89 ?m, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to for the treatment and/or prophylaxis of thromboembolic disorders.
    Type: Application
    Filed: March 31, 2016
    Publication date: August 25, 2016
    Inventors: Jatin Patel, Charles Frost, Jingpin Jia, Chandra Vemavarapu
  • Apixaban formulations
    Patent number: 9326945
    Abstract: Compositions comprising crystalline apixaban particles having a D90 equal to or less than 89 ?m, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to for the treatment and/or prophylaxis of thromboembolic disorders.
    Type: Grant
    Filed: February 24, 2011
    Date of Patent: May 3, 2016
    Assignees: Bristol-Myers Squibb Company, Pfizer Inc.
    Inventors: Jatin Patel, Charles Frost, Jingpin Jia, Chandra Vemavarapu
  • APIXABAN FORMULATIONS
    Publication number: 20130045245
    Abstract: Compositions comprising crystalline apixaban particles having a D90 equal to or less than 89 ?m, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to for the treatment and/or prophylaxis of thromboembolic disorders.
    Type: Application
    Filed: February 24, 2011
    Publication date: February 21, 2013
    Applicants: PFIZER, INC., BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Jatin Patel, Charles Frost, Jingpin Jia, Chandra Vemavarapu